論文業績

原著論文（欧文）

  1. Nagamizu M, Hotta Y, Morozumi I, Nakamura D, Hori M, Otsuka Y, Takemoto R, Horita Y, Wakita E, Morishita N, Kondo M, Furukawa‐Hibi Y, Kimura K. Adverse effects induced by osimertinib based on the dose per body constitutional parameters: A retrospective observational study. BPB rep. 7(4):132-140. 2024
  2. Mimura Y, Naiki T, Sugiyama Y, Tasaki Y, Odagiri K, Etani T, Nagai T, Iida M, Kimura Y, Ito N, Hotta Y, Yasui T, and Furukawa-Hibi Y. Cachexia index Is a prognostic indicator in patients with metastatic urothelial carcinoma treated with systemic chemotherapy. Cancer Diagn progn. 2024 Jul. 4(4): 475-481. 2024 Jul-Aug.
  3. Iida M, Horita Y, Asaoka M, Ohashi K, Noda M, Wachino C, Hirose T, Nomura Y, Hisada Y, Nagamizu M, Kawahara M, Morishita N, Kondo M, Hotta Y, Nakamura A, Furukawa‐Hibi Y. Evaluation of target area under the concentration-time curve of vancomycin in an initial dosing design: a retrospective cohort study. J Antimicrob Chemother, 79(10):2518-2527. 2024.
  4. Nakamura D, Yanagita T, Fujii Y, Watanabe K, Suzuki T, Ushigome H, Nishigaki R, Sugimura N, Tanaka M, Ogawa R, Takahashi H, Shimura T, Hotta Y, Matsuo Y, Kondo M, Furukawa-Hibi Y, Takiguchi S. Unanticipated pathological clearance in two cases of clinical T4b dMMR/MSI-h advanced colorectal cancer: the potential of immune checkpoint inhibitors despite positive positron-emission tomography results. Surg Case Rep. 10(1):105. 2024.
  5. MimuraY, Yasujima T, Inoue K, Akino S, Namba C, Kusuhara H, Sekiguchi Y, Ohta K, Yamashiro T, and Yuasa Y. SLC35G1 is a highly chloride-sensitive transporter responsible for the basolateral membrane transport in intestinal citrate absorption. eLife. 2024 Nov. 13:RP98853.
  6. Hotta Y, Oyama K, Yoshida T, Ieda N, Mori T, Horita Y, Kataoka T, Furukawa-Hibi Y, Ohya S, Nakagawa H, Kimura K. The effects of a red-light controllable nitric oxide donor, NORD-1, on erectile dysfunction in rats with streptozotocin induced diabetes mellitus. World J Mens Health. 43(1):197-204. 2025.
  7. Sanagawa A, Hayakawa T, Yamamoto A, Hotta Y, Furukawa-Hibi Y, Morita A. Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma. Drugs R D. 24(2):227-238. 2024.
  8. Kataoka T, Ito H, Mori T, Hotta Y, Sanagawa A, Maeda Y, Furukawa-Hibi Y, Kimura K. Testosterone improved erectile function by upregulating transcriptional expression of growth factors in late androgen replacement therapy model rats. Int J Impot Res. 36(4):437-442. 2024.
  9. Hamamoto S, Tasaki Y, Morikawa T, Naiki T, Etani T, Taguchi K, Iwatsuki S, Unno R, Takeda T, Nagai T, Kawase K, Mimura Y, Sugiyama Y, Okada A, Furukawa-Hibi Y and Yasui T. Efficacy and Safety of Immuno-Oncology Plus Tyrosine Kinase Inhibitors as Late-Line Combination Therapy for Patients with Advanced Renal Cell Carcinoma. J. Clin. Med. 2024 Jun 7;13(12):3365.
  10. Hamamoto S, Tasaki Y, Yamashita S, Furukawa J, Fujita K, Tomida R, Miyake M, Ito N, Iwamoto H, Sugiyama Y, Taguchi K, and Yasui T. External validation of hemoglobin and neutrophil levels as predictors of the effectiveness of ipilimumab plus nivolumab for treating renal cell carcinoma. Front. Oncol. 2024 Sep 2:14:1400041.
  11. Tasaki Y, Ito N, Mimura Y, Sugiyama Y, Ogawa R, Shimura T, Nakamura M, Kawakita D, Hamamoto S, Uemura T, Yokota K, Iida M, Odagiri K, Kimura Y, Hotta Y, Komatsu H, Okuda K, Niimi A, Yasui T, Iwasaki S, Morita A, Kataoka H, Takiguchi S, Furukawa-Hibi Y. Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients. Asia Pac J Clin Oncol. 2024 Apr 29.
  12. Kawata R, Hotta Y, Kataoka T, Hibi Y, Ota Y, Hamakawa T, Kubota Y, Yasui T, Kimura K. Short-term effects of suprapubic catheterization on detrusor muscle contraction in a rat model of postoperative urinary dysfunction. Continence. 10. 101309. 2024.
  13. Kinoshita S, Takemoto M, Asaoka M, Haraguchi Y, Adachi T, Iida S, Komatsu H. COVID-19 in patients receiving treatment at an outpatient chemotherapy unit: A Short Communication. Jpn J Clin Oncol, Sep. 17, 2024.
  14. Inoh Y, Ito N, Yokawa S, Suzuki R, Furuno T. Surface charge, but not size, of liposomes is involved in the suppression of rat basophilic leukemia (RBL-2H3) cell degranulation mediated by Akt phosphorylation, Cell Biol Int 2024 Oct;(10):1463-1472

 

原著論文（和文, 査読あり）

  1. 飯田萌子：優秀演題賞を受賞して「バンコマイシン投与早期の急性腎障害予測因子の探索と2日目AUCの閾値推定」. TDM研究 41 (4) 141-144, 2024.

 

著書・総説, 論文（英文, 査読あり）

  1. Kataoka T, Hotta Y, Kimura K. A review of experimental techniques for erectile function researches and development of medical technology using animal erectile dysfunction models in sexual and reproductive medicine. Reproductive Medicine and Biology. 22(1):e12513. 2023.

 

著書・総説, 論文（和文, 査読なし）

  1. 堀田祐志, 野田みすず, 日比陽子：特集 医薬品使用時に生じる排尿障害. 現代医学. 71（1）：51-55. 2024.
  2. 堀田康弘, 堀田祐志, 木村和哲：AUCに基づいたバンコマイシンの投与設計に対応した新規TDM支援ソフトの開発, 医療の広場, 2024年4月.